Late-onset Ocular Toxicity Presenting as Uveitis Caused by Crizotinib
- 6 May 2021
- journal article
- case report
- Published by Taylor & Francis in Neuro-Ophthalmology
- Vol. 46 (1) , 44-49
Abstract
A 64-year-old female suffering from lung cancer was treated with crizotinib. Two years later, whitish massive optic disc oedema was observed in the right eye. The fluorescein angiography results were suggestive of uveitis but also revealed leakage from the optic disc, retinal veins, and capillaries in the posterior retina and the periphery. These findings remained for over a year without deterioration of vision and disappeared immediately after crizotinib was replaced with alectinib. Late-onset ocular toxicity by crizotinib was strongly suspected, given the clinical course. This is the first report precisely documenting crizotinib-induced morphological changes in the optic disc and retina.Keywords
Funding Information
- JSPS KAKENHI (JP20K09767)
This publication has 18 references indexed in Scilit:
- Drug-induced uveitis: A reviewIndian Journal Of Ophthalmology, 2020
- Crizotinib-Induced Abnormal Signal Processing in the RetinaPLOS ONE, 2015
- Optic Neuropathy and Blindness Associated With Crizotinib for Non–Small-Cell Lung Cancer With EML4-ALK TranslocationJournal of Clinical Oncology, 2015
- Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensusLung Cancer, 2015
- FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase RearrangementsThe Oncologist, 2014
- Toxic optic neuropathiesCurrent Opinion in Ophthalmology, 2013
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyThe Lancet Oncology, 2012
- Effects of Age, Sex, and Axial Length on the Three-Dimensional Profile of Normal Macular Layer StructuresInvestigative Ophthalmology & Visual Science, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Drug-Induced UveitisSurvey of Ophthalmology, 1998